Further supporting this theory, both genetic (e.g., ApoE4, TREM2, RIN3, CLU and PTK2B) and nongenetic (e.g., diabetes and obesity) risk factors for late-onset AD have also been identified to influence Aβ generation and/or Aβ clearance [8]. This evidence concerns the gene APOE and Alzheimer disease.